Back to Journals » Breast Cancer: Targets and Therapy » Volume 9

Breast Cancer: Targets and Therapy


Archive: Volume 9, 2017

Prevention and treatment of acute and chronic radiodermatitis

Seité S, Bensadoun RJ, Mazer JM

Breast Cancer: Targets and Therapy 2017, 9:551-557

Published Date: 2 November 2017

Increased risk of breast cancer in neurofibromatosis type 1: current insights

Howell SJ, Hockenhull K, Salih Z, Evans DG

Breast Cancer: Targets and Therapy 2017, 9:531-536

Published Date: 21 August 2017

Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence

Piva R, Ticconi F, Ceriani V, Scalorbi F, Fiz F, Capitanio S, Bauckneht M, Cittadini G, Sambuceti G, Morbelli S

Breast Cancer: Targets and Therapy 2017, 9:461-471

Published Date: 4 July 2017

High glucose levels promote the proliferation of breast cancer cells through GTPases

Hou Y, Zhou M, Xie J, Chao P, Feng Q, Wu J

Breast Cancer: Targets and Therapy 2017, 9:429-436

Published Date: 13 June 2017

Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis

Delou JM, Vignal GM, Índio-do-Brasil V, Accioly MT, da Silva TS, Piranda DN, Sobral-Leite M, Carvalho MA, Capella MA, Vianna-Jorge R

Breast Cancer: Targets and Therapy 2017, 9:415-428

Published Date: 10 June 2017

Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort

El Chediak A, Alameddine RS, Hakim A, Hilal L, Abdel Massih S, Hamieh L, Mukherji D, Temraz S, Charafeddine M, Shamseddine A

Breast Cancer: Targets and Therapy 2017, 9:407-414

Published Date: 10 June 2017

Single nucleotide polymorphisms and unacceptable late toxicity in breast cancer adjuvant radiotherapy: a case report

Lazzari G, Natalicchio MI, Terlizzi A, Perri F, Silvano G

Breast Cancer: Targets and Therapy 2017, 9:401-406

Published Date: 29 May 2017

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

Johnson R, Sabnis N, Sun X, Ahluwalia R, Lacko AG

Breast Cancer: Targets and Therapy 2017, 9:383-392

Published Date: 2 June 2017

The regulation of steroid receptors by epigallocatechin-3-gallate in breast cancer cells

Hallman K, Aleck K, Quigley M, Dwyer B, Lloyd V, Szmyd M, Dinda S

Breast Cancer: Targets and Therapy 2017, 9:365-373

Published Date: 24 May 2017

Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer

Murillo-Ortiz B, Martínez-Garza S, Cárdenas Landeros V, Cano Velázquez G, Suárez Garci­a D

Breast Cancer: Targets and Therapy 2017, 9:359-364

Published Date: 23 May 2017

Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro

Goyette S, Liang Y, Mafuvadze B, Cook MT, Munir M, Hyder SM

Breast Cancer: Targets and Therapy 2017, 9:347-357

Published Date: 19 May 2017

Current perspectives on CHEK2 mutations in breast cancer

Apostolou P, Papasotiriou I

Breast Cancer: Targets and Therapy 2017, 9:331-335

Published Date: 12 May 2017

Imprint cytology versus frozen section analysis for intraoperative assessment of sentinel lymph node in breast cancer

Petropoulou T, Kapoula A, Mastoraki A, Politi A, Spanidou-Karvouni E, Psychogios I, Vassiliou I, Arkadopoulos N

Breast Cancer: Targets and Therapy 2017, 9:325-330

Published Date: 5 May 2017

Prognostic value of histone chaperone FACT subunits expression in breast cancer

Attwood K, Fleyshman D, Prendergast L, Paszkiewicz G, Omilian AR, Bshara W, Gurova K

Breast Cancer: Targets and Therapy 2017, 9:301-311

Published Date: 3 May 2017

Metaplastic breast carcinoma with upper limb gangrene

Rajan R, Abdullah N, Abdullah NMA, Mohd Kassim AY

Breast Cancer: Targets and Therapy 2017, 9:297-299

Published Date: 2 May 2017

Improved immediate breast reconstruction as a result of oncoplastic multidisciplinary meeting

El Gammal MM, Lim M, Uppal R, Sainsbury R

Breast Cancer: Targets and Therapy 2017, 9:293-296

Published Date: 28 April 2017

Lymphoscintigraphy detecting alterations of upper limb lymphatic flow following early sentinel lymph node biopsy in breast cancer

Sarri AJ, Tinois da Silva E, Vieira RAC, Koga KH, Cação PHM, Sarri VC, Moriguchi SM

Breast Cancer: Targets and Therapy 2017, 9:279-285

Published Date: 19 April 2017

Mentha arvensis (Linn.)-mediated green silver nanoparticles trigger caspase 9-dependent cell death in MCF7 and MDA-MB-231 cells

Banerjee PP, Bandyopadhyay A, Harsha SN, Policegoudra RS, Bhattacharya S, Karak N, Chattopadhyay A

Breast Cancer: Targets and Therapy 2017, 9:265-278

Published Date: 18 April 2017

Intraoperative radiation therapy for breast cancer patients: current perspectives

Dutta SW, Showalter SL, Showalter TN, Libby B, Trifiletti DM

Breast Cancer: Targets and Therapy 2017, 9:257-263

Published Date: 18 April 2017

Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients

Charoenchokthavee W, Areepium N, Panomvana D, Sriuranpong V

Breast Cancer: Targets and Therapy 2017, 9:249-256

Published Date: 15 April 2017

Granular cell tumor in breast: a case report

Castillo Lara M, Martínez Herrera A, Torrejón Cardoso R, Lubián López DM

Breast Cancer: Targets and Therapy 2017, 9:245-248

Published Date: 11 April 2017

Tumescent mastectomy: the current indications and operative tips and tricks

Khater A, Mazy A, Gad M, Taha Abd Eldayem O, Hegazy M

Breast Cancer: Targets and Therapy 2017, 9:237-243

Published Date: 30 March 2017

The role of the chemokine receptor XCR1 in breast cancer cells

Yang XL, Qi LG, Lin FJ, Ou ZL

Breast Cancer: Targets and Therapy 2017, 9:227-236

Published Date: 29 March 2017

Breast cancer in patients with Li–Fraumeni syndrome – a case-series study and review of literature

Nandikolla AG, Venugopal S, Anampa J

Breast Cancer: Targets and Therapy 2017, 9:207-215

Published Date: 23 March 2017

Validation of Health Behavior and Stages of Change Questionnaire

Gonzalez-Ramirez LP, De la Roca-Chiapas JM, Colunga-Rodriguez C, Preciado-Serrano MDL, Daneri-Navarro A, Pedroza-Cabrera FJ, Martinez-Arriaga RJ

Breast Cancer: Targets and Therapy 2017, 9:199-205

Published Date: 22 March 2017

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Jernström S, Hongisto V, Leivonen SK, Due EU, Tadele DS, Edgren H, Kallioniemi O, Perälä M, Mælandsmo GM, Sahlberg KK

Breast Cancer: Targets and Therapy 2017, 9:185-198

Published Date: 21 March 2017

The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells

Hallman K, Aleck K, Dwyer B, Lloyd V, Quigley M, Sitto N, Siebert AE, Dinda S

Breast Cancer: Targets and Therapy 2017, 9:153-161

Published Date: 10 March 2017

Mastectomy skin flap necrosis: challenges and solutions

Robertson SA, Jeevaratnam JA, Agrawal A, Cutress RI

Breast Cancer: Targets and Therapy 2017, 9:141-152

Published Date: 13 March 2017

Intensity modulated radiation therapy for breast cancer: current perspectives

Buwenge M, Cammelli S, Ammendolia I, Tolento G, Zamagni A, Arcelli A, Macchia G, Deodato F, Cilla S, Morganti AG

Breast Cancer: Targets and Therapy 2017, 9:121-126

Published Date: 6 March 2017

CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study

Wickramage I, Tennekoon KH, Ariyaratne MAY, Hewage AS, Sundralingam T

Breast Cancer: Targets and Therapy 2017, 9:111-120

Published Date: 6 March 2017

An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors

Koleck TA, Bender CM, Clark BZ, Ryan CM, Ghotkar P, Brufsky A, McAuliffe PF, Rastogi P, Sereika SM, Conley YP

Breast Cancer: Targets and Therapy 2017, 9:95-110

Published Date: 3 March 2017

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity

Sambi M, Haq S, Samuel V, Qorri B, Haxho F, Hill K, Harless W, Szewczuk MR

Breast Cancer: Targets and Therapy 2017, 9:85-93

Published Date: 28 February 2017

The predictors of poor quality of life in a sample of Saudi women with breast cancer

Ahmed AE, Alharbi AG, Alsadhan MA, Almuzaini AS, Almuzaini HS, Ali YZ, Jazieh AR

Breast Cancer: Targets and Therapy 2017, 9:51-58

Published Date: 9 February 2017

Docetaxel-associated myalgia–arthralgia syndrome in patients with breast cancer

Seguin C, Kovacevich N, Voutsadakis IA

Breast Cancer: Targets and Therapy 2017, 9:39-44

Published Date: 23 January 2017

Breast cancer in Mongolia: an increasingly important health policy issue

Demchig D, Mello-Thoms C, Brennan PC

Breast Cancer: Targets and Therapy 2017, 9:29-38

Published Date: 20 January 2017

Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women

Murillo-Ortiz B, Martínez-Garza S, Suárez García D, Castillo Valenzuela RDC, García Regalado JF, Cano Velázquez G

Breast Cancer: Targets and Therapy 2017, 9:21-27

Published Date: 13 January 2017

Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells

Cook MT, Liang Y, Besch-Williford C, Hyder SM

Breast Cancer: Targets and Therapy 2017, 9:9-19

Published Date: 23 December 2016

Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms

Villa Guzmán JC, Espinosa J, Cervera R, Delgado M, Patón R, Cordero García JM

Breast Cancer: Targets and Therapy 2017, 9:1-7

Published Date: 23 December 2016